Home › Funds › Two Sigma Investments › PLX
Two Sigma Investments position in PLX
PROTALIX BIOTHERAPEUTICS INC · Health Care
Latest position (Q2 2026)42.52K sh
Reported value held$99.06K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 25.51K | $28.00K | New |
| Q3 2022 | 10.35K | $11.00K | Reduce |
| Q4 2022 | 10.13K | $13.87K | Reduce |
| Q1 2023 | 194.09K | $407.60K | Add |
| Q2 2023 | 55.12K | $110.25K | Reduce |
| Q3 2023 | 47.30K | $78.52K | Reduce |
| Q4 2023 | 19.60K | $34.89K | Reduce |
| Q1 2025 | 86.35K | $221.07K | New |
| Q1 2025 | 86.35K | $221.07K | New |
| Q2 2025 | 71.54K | $105.88K | Reduce |
| Q2 2025 | 71.54K | $105.88K | Reduce |
| Q1 2026 | 18.13K | $39.34K | New |
| Q2 2026 | 42.52K | $99.06K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLX
- BlackRock Inc 4.05M sh · $9.43M · Q2 2026
- Renaissance Technologies 1.10M sh · $2.55M · Q2 2026
- Geode Capital Management 980.00K sh · $2.28M · Q2 2026
- Northern Trust Corp 922.34K sh · $2.15M · Q2 2026
- Goldman Sachs Group 475.92K sh · $1.11M · Q2 2026
- Marshall Wace 452.76K sh · $1.05M · Q2 2026
- Vanguard Group 488.55K sh · $879.39K · Q4 2025
- BNY Mellon 232.99K sh · $542.87K · Q2 2026
- Charles Schwab Investment Management 180.38K sh · $420.29K · Q2 2026
- Millennium Management 171.53K sh · $399.68K · Q2 2026
- AQR Capital Management 167.83K sh · $391.04K · Q2 2026
- Lazard Asset Management 165.56K sh · $385.76K · Q2 2026